Support

GlaxoSmithKline: Namibia Sanitation & Hygiene Program

Nearly 1.3 million of Namibia's population of just over 2 million do not have access to proper toilet facilities, including 84% of all people living in rural areas. Diarrhea is the second highest cause of pediatric admissions in Namibia and is responsible for more than 30% of deaths in children under the age of five. In order to achieve the UN Millennium Development Goals (MDGs), the Namibian government's aim for 2015 is to ensure that at least 62% of people will have access to adequate sanitation.

GlaxoSmithKline & Leonard Cheshire Disability in Sri Lanka

GlaxoSmithKline supports Leonard Cheshire Disability (LCD) in Galle, southern Sri Lanka. Following the devastating tsunami in 2004, LCD set up the Disability Resource Centre, the first of its kind in the area to support disabled peoples access to health and rehabilitation services, inclusive education and livelihood opportunities. Part of the project focuses on increasing young disabled people's involvement in the community, mobilizing them to campaign for a better future. Achieved through self-help groups, it will allow them to advocate for their own rights.

GlaxoSmithKline & Integrated Management of Childhood Illness

The World Health Organization (WHO) and UNICEF developed Integrated Management of Childhood Illness (IMCI) as an improved delivery strategy for child survival interventions. GlaxoSmithKline has been involved with IMCI since 1996 when it initiated an unique partnership with the South African Ministry of Health. Since then, GSK has entered into public-private partnership agreements with WHO, UNICEF, National Ministries of Health and/or NGOs for the implementation of the IMCI strategy or components thereof in Ethiopia, Namibia, Nigeria, Ghana and Kenya.

GlaxoSmithKline & Access to Malaria Care

GlaxoSmithKline offers its antimalarials at not-for-profit prices to public sector customers and not-for-profit organizations in 64 countries - all the Least Developed Countries and all of sub-Saharan Africa. All CCM projects fully funded by the Global Fund to Fight AIDS TB and Malaria are also eligible. GSK does not make a profit at these prices, but it does cover its costs, so it can sustain supply of these high-quality products for as long as they are needed. These prices apply to orders of any size and include insurance and freight costs.

GlaxoSmithKline - Other HIV/AIDS Capacity-Building Initiatives

The GlaxoSmithKline Foundation supports a range of HIV/AIDS-related programs around the world. Since 1998, the GSK France Foundation has supported 86 programs to improve healthcare through prevention, education and training in 14 developing countries. The GSK Foundation Canada also supports community programs in Africa, including AIDS Orphans Uganda, working with the African Medical Research Foundation (AMREF).

Ghazipur Children's Hospital

Pfizer Spain is supporting the Sabera Foundation, which runs a small Children's Hospital in Ghazipur, in the outskirts of Calcutta in India. The hospital provides specialized residential health care and rehabilitation services for the children of poor families. Pfizer helps fund maintenance of the building and the hospital's operating expenses infrastructures and makes available the company's expertise in health care. Therapeutic areas covered include physiotherapy, tuberculosis and ophthalmology. The hospital also provides out-patient support to the surrounding community.

GAVI Alliance

The GAVI Alliance is a community of pharmaceutical companies seeking to reduce childhood morbidity.

Fuyang AIDS Orphan Salvation

The Fuyang AIDS Orphan Salvation provides aid to children with HIV/AIDS in eastern China.

End Violence against Women and Prevent HIV and AIDS Program

Globally, violence against women is both a cause and a consequence of HIV/AIDS: women facing violence within intimate relationships often cannot negotiate safer sex practices, such as condom use. Rape and harmful practices such as female genital mutilation also spread the virus. In addition to untenable levels of stigma and discrimination from the community, women who test positive for HIV are often subjected to physical abuse from partners and can face eviction from their homes.

Empowering Africa's Young People Initiative

Johnson & Johnson partners with the International Youth Foundation on the HIV/AIDS prevention program Empowering Africa's Young People Initiative in Zambia. Support from Johnson & Johnson enables the International Youth Foundation to expand its services and training, including increasing the number of peer educators who teach other youth in their communities about preventing the spread of HIV/AIDS. Since the partnership began in 2006, more than 1,900 peer educators have been trained.

Pages